In vivo, decreasing inoculation doses of 5 × 103 and 1 × 103 HCC827 CAMK2A-KD cells grown as monolayers, respectively, gave rise to significantly suppressed tumor growth rates (Fig. 2g and Supplementary Fig. 3c). The gene discussed is CAMK2A; the disease is neoplasm.